Abstract
We present a mortality case showcasing t(9;11)-positive acute myeloid leukemia/juvenile myelomonocytic leukemia (AML/JMML) overlap to shed light on this lethal molecular subtype of AML. In this case, the flawed assumption that JMML was to blame impeded the prompt undertaking of appropriate treatment for AML in our 14-month-old patient. This article aims to scrutinize the catastrophic sequel of such an overlap in leukemia and refutes the contemporary diagnostic methods.
Keywords
Publication details
- DOI
- 10.5001/omj.2019.99
- Journal
- Oman Medical Journal
- Publisher
- Oman Medical Specialty Board
- Open access
- Gold open access
Cite this article
APA 7
Saad, A. A., Beshlawi, I., Zachariah, M., & Wali, Y. (2019). KMT2A-MLLT3 AML Masquerading as JMML may Disguise Fatal Leukemia. Oman Medical Journal. https://doi.org/10.5001/omj.2019.99
MLA 9
Saad, Ashraf Abdullah, et al. "KMT2A-MLLT3 AML Masquerading as JMML may Disguise Fatal Leukemia." Oman Medical Journal, 2019. https://doi.org/10.5001/omj.2019.99.
Chicago (author–date)
Saad, Ashraf Abdullah, Ismail Beshlawi, Mathew Zachariah, and Yasser Wali. 2019. "KMT2A-MLLT3 AML Masquerading as JMML may Disguise Fatal Leukemia." Oman Medical Journal. https://doi.org/10.5001/omj.2019.99.
Harvard
Saad, A. A., Beshlawi, I., Zachariah, M. and Wali, Y. (2019) 'KMT2A-MLLT3 AML Masquerading as JMML may Disguise Fatal Leukemia', Oman Medical Journal. doi:10.5001/omj.2019.99.
Vancouver
Saad AA, Beshlawi I, Zachariah M, Wali Y. KMT2A-MLLT3 AML Masquerading as JMML may Disguise Fatal Leukemia. Oman Medical Journal. 2019. doi:10.5001/omj.2019.99
IEEE
A. A. Saad, I. Beshlawi, M. Zachariah, and Y. Wali, "KMT2A-MLLT3 AML Masquerading as JMML may Disguise Fatal Leukemia," Oman Medical Journal, 2019, doi: 10.5001/omj.2019.99.